Masaki Munakata

Randomized phase II trial of nimotuzumab plus irinotecan versus irinotecan alone as second-line therapy for patients with advanced gastric cancer

Taroh Satoh, Kyung Hee Lee, Sun Young Rha et al. · Gastric Cancer · 2014 · 115 citations · Full text

Medicine, Oncology, Pharmacology +16

Genotype‐directed, dose‐finding study of irinotecan in cancer patients with <i>UGT1A1*28</i> and/or <i>UGT1A1*6</i> polymorphisms

Taroh Satoh, Takashi Ura, Yasuhide Yamada et al. · Cancer Science · 2011 · 105 citations · Full text

Medicine, Oncology, Pharmacology +14

Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer

Kensei Yamaguchi, T Shimamura, Ichinosuke Hyodo et al. · British Journal of Cancer · 2006 · 68 citations · Full text

Medicine, Oncology, Pharmacology +17

Hepatic Arterial Infusion of Mitomycin C with Degradable Starch Microspheres for Unresectable Intrahepatic Cholangiocarcinoma

Kohei Shitara, I Ikami, Masaki Munakata et al. · Clinical Oncology · 2008 · 40 citations

Medicine, Pharmacology, Surgery +17

Randomised phase II trial of irinotecan plus S-1 in patients with gemcitabine-refractory pancreatic cancer

Tatsuya Ioka, Yoshito Komatsu, Nobumasa Mizuno et al. · British Journal of Cancer · 2017 · 26 citations · Full text

Medicine, Oncology, Pharmacology +11